Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
34 Ergebnisse
| MB80XF |  | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 120,628 | 132,700 | 1,600 | 58,360 % | - | Morgan Stanley | |
| MD2MNN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 140,087 | 140,087 | 1,765 | 56,042 % | - | Morgan Stanley | |
| MD328F | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 207,088 | 207,088 | 2,878 | 35,018 % | - | Morgan Stanley | |
| MG22CE | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 122,733 | 122,733 | 1,612 | 61,488 % | - | Morgan Stanley | |
| MG34NZ | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 248,516 | 248,516 | 4,704 | 22,018 % | - | Morgan Stanley | |
| MG7KE7 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 152,086 | 167,300 | 1,898 | 47,503 % | - | Morgan Stanley | |
| MG7XKN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 162,638 | 178,910 | 2,023 | 43,860 % | - | Morgan Stanley | |
| MG9FVK | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 172,487 | 189,740 | 2,159 | 40,462 % | - | Morgan Stanley | |
| MG9FWP | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 189,736 | 189,736 | 2,427 | 40,463 % | - | Morgan Stanley | |
| MJ8CFY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 205,114 | 205,114 | 2,758 | 35,637 % | - | Morgan Stanley | |
| MJ8U9Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 186,149 | 204,770 | 2,378 | 35,745 % | - | Morgan Stanley | |
| MJ8V0F | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 216,140 | 216,140 | 3,044 | 32,178 % | - | Morgan Stanley | |
| MK1TWC | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 180,144 | 180,144 | 2,268 | 43,473 % | - | Morgan Stanley | |
| MK6WXM | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 201,224 | 221,350 | 2,794 | 30,543 % | - | Morgan Stanley | |
| MK6X8Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 232,414 | 232,414 | 3,585 | 27,071 % | - | Morgan Stanley | |
| MK7AJZ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 220,968 | 243,070 | 3,207 | 23,727 % | - | Morgan Stanley | |
| MK7QDV | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 253,681 | 253,681 | 4,676 | 20,398 % | - | Morgan Stanley | |
| MK7ZT1 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 230,223 | 253,250 | 3,544 | 20,533 % | - | Morgan Stanley | |
| MM0WK3 | | BeiGene Ltd. (ADRs)/Faktor/Short [3]/MS | - | - | put | BeiGene Ltd. (ADRs) | 414,090 | 414,090 | 3,019 | 29,937 % | - | Morgan Stanley | |
| MM1Z6H | | BeiGene Ltd. (ADRs)/Faktor/Short [4]/MS | - | - | put | BeiGene Ltd. (ADRs) | 388,209 | 388,209 | 4,018 | 21,816 % | - | Morgan Stanley | |
| MM2KYV | | BeiGene Ltd. (ADRs)/KO/Put [endlos]/MS | - | - | put | BeiGene Ltd. (ADRs) | 397,472 | 397,472 | 3,921 | 24,723 % | - | Morgan Stanley | |
| MM4E53 | | BeiGene Ltd. (ADRs)/Faktor/Short [5]/MS | - | - | put | BeiGene Ltd. (ADRs) | 372,681 | 372,681 | 4,994 | 16,943 % | - | Morgan Stanley | |
| MN337Y | | BeiGene Ltd. (ADRs)/Faktor/Short [2]/MS | - | - | put | BeiGene Ltd. (ADRs) | 465,851 | 465,851 | 2,006 | 46,179 % | - | Morgan Stanley | |
| MN8NH1 | | BeiGene Ltd. (ADRs)/Faktor/Short [8]/MS | - | - | put | BeiGene Ltd. (ADRs) | 349,388 | 349,388 | - | 9,634 % | - | Morgan Stanley | |
| MN8NH2 | | BeiGene Ltd. (ADRs)/Faktor/Short [10]/MS | - | - | put | BeiGene Ltd. (ADRs) | 341,624 | 341,624 | - | 7,198 % | - | Morgan Stanley | |
| MN8NK4 | | BeiGene Ltd. (ADRs)/Faktor/Long [8]/MS | - | - | call | BeiGene Ltd. (ADRs) | 271,814 | 271,814 | - | 14,708 % | - | Morgan Stanley | |
| MN8NK5 | | BeiGene Ltd. (ADRs)/Faktor/Long [10]/MS | - | - | call | BeiGene Ltd. (ADRs) | 279,580 | 279,580 | - | 12,271 % | - | Morgan Stanley | |
| MN95UH | | BeiGene Ltd. (ADRs)/Faktor/Long [2]/MS | - | - | call | BeiGene Ltd. (ADRs) | 155,322 | 155,322 | - | 51,261 % | - | Morgan Stanley | |
| MR101N | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 248,516 | 248,516 | - | 22,018 % | - | Morgan Stanley | |
| MR1FCB | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 207,097 | 207,097 | - | 35,015 % | - | Morgan Stanley | |
| MR1FCC | | BeiGene Ltd. (ADRs)/Faktor/Long [4]/MS | - | - | call | BeiGene Ltd. (ADRs) | 232,984 | 232,984 | - | 26,892 % | - | Morgan Stanley | |
| MR2QPY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 251,129 | 276,250 | 4,614 | 13,316 % | - | Morgan Stanley | |
| MR2QXQ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 276,242 | 276,242 | 6,870 | 13,318 % | - | Morgan Stanley | |
| MR4DGB | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 300,000 | 300,000 | - | 5,863 % | - | Morgan Stanley |